Related references
Note: Only part of the references are listed.Determinants of orofacial clefting II: Effects of 5-Aza-2 '-deoxycytidine on gene methylation during development of the first branchial arch
Ratnam S. Seelan et al.
REPRODUCTIVE TOXICOLOGY (2017)
Determinants of orofacial clefting I: Effects of 5-Aza-2 '-deoxycytidine on cellular processes and gene expression during development of the first branchial arch
Partha Mukhopadhyay et al.
REPRODUCTIVE TOXICOLOGY (2017)
Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes
Aurelie Van Tongelen et al.
CANCER LETTERS (2017)
Distinct and overlapping DNMTI interactions with multiple transcription factors in erythroid cells: Evidence for co-repressor functions
Dimitris N. Papageorgiou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Combining Epigenetic and Immunotherapy to Combat Cancer
Katherine B. Chiappinelli et al.
CANCER RESEARCH (2016)
Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis
Iona C. Evans et al.
CLINICAL SCIENCE (2016)
Role of TET enzymes in DNA methylation, development, and cancer
Kasper Dindler Rasmussen et al.
GENES & DEVELOPMENT (2016)
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Andrew P. Feinberg et al.
NATURE REVIEWS GENETICS (2016)
The molecular hallmarks of epigenetic control
C. David Allis et al.
NATURE REVIEWS GENETICS (2016)
Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells
Elisabetta Tabolacci et al.
EPIGENETICS & CHROMATIN (2016)
The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors
Allen S. Yang et al.
EPIGENOMICS (2016)
5-Hydroxymethylcytosine Marks Sites of DNA Damage and Promotes Genome Stability
Georgia Rose Kafer et al.
CELL REPORTS (2016)
Epigenomic Co-localization and Co-evolution Reveal a Key Role for 5hmC as a Communication Hub in the Chromatin Network of ESCs
David Juan et al.
CELL REPORTS (2016)
The role of DNA damage responses in p53 biology
Daniel Speidel
ARCHIVES OF TOXICOLOGY (2015)
Effect of DNA methylation profile on OATP3A1 and OATP4A1 transcript levels in colorectal cancer
Agnieszka Anna Rawluszko-Wieczorek et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues
Natalie S. Shenker et al.
BMC CANCER (2015)
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
David Roulois et al.
CELL (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Digging deep into dirty'' drugs - modulation of the methylation machinery
Lisa Pleyer et al.
DRUG METABOLISM REVIEWS (2015)
The interplay of histone modifications - writers that read
Tianyi Zhang et al.
EMBO REPORTS (2015)
The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cells
Basudev Chowdhury et al.
SCIENTIFIC REPORTS (2015)
Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma
Sahar Olsadat Sajadian et al.
CLINICAL EPIGENETICS (2015)
Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer
Nilufer Sayar et al.
CLINICAL EPIGENETICS (2015)
Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries
Patompon Wongtrakoongate
WORLD JOURNAL OF STEM CELLS (2015)
The DNA Hypomethylating Agent, 5-aza-2 '-Deoxycytidine, Enhances Tumor Cell Invasion Through a Transcription-Dependent Modulation of MMP-1 Expression in Human Fibrosarcoma Cells
Mathilde Poplineau et al.
MOLECULAR CARCINOGENESIS (2015)
δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells
Akihiko Fukagawa et al.
CANCER MEDICINE (2015)
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang et al.
CANCER CELL (2014)
Gene expression profiling of replicative and induced senescence
Maggie Purcell et al.
CELL CYCLE (2014)
5-Hydroxymethylcytosine: A stable or transient DNA modification?
Maria A. Hahn et al.
GENOMICS (2014)
Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation
Magdalena K. Poplutz et al.
IMMUNOBIOLOGY (2014)
The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions
Manuel Luis Orta et al.
NUCLEIC ACIDS RESEARCH (2014)
The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes
Y. Cai et al.
ONCOGENE (2014)
Pathway landscapes and epigenetic regulation in breast cancer and melanoma cell lines
Mariama El Baroudi et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2014)
Diversity of two forms of DNA methylation in the brain
Yuanyuan Chen et al.
FRONTIERS IN GENETICS (2014)
Global loss of DNA methylation uncovers intronic enhancers in genes showing expression changes
Adam Blattler et al.
GENOME BIOLOGY (2014)
β,β-Carotene 15,15′-monooxygenase and its substrate β-carotene modulate migration and invasion in colorectal carcinoma cells
Diep Ngoc Thi Pham et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer
Marta Kulis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma
Xiaoying Zhang et al.
JOURNAL OF GASTROENTEROLOGY (2013)
TETonic shift: biological roles of TET proteins in DNA demethylation and transcription
William A. Pastor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
(Some) Cellular Mechanisms Influencing the Transcription of Human Endogenous Retrovirus, HERV-Fc1
Magdalena Janina Laska et al.
PLOS ONE (2013)
p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs
Katerina I. Leonova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A
Jian Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer
Tingting Yao et al.
VIROLOGY JOURNAL (2013)
Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia
Evgeny A. Moskalev et al.
BMC CANCER (2012)
Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research
N. Shenker et al.
BRITISH JOURNAL OF CANCER (2012)
Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications
S. Coral et al.
BRITISH JOURNAL OF CANCER (2012)
Epigenetic Resensitization to Platinum in Ovarian Cancer
Daniela Matei et al.
CANCER RESEARCH (2012)
Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non-Small Cell Lung Cancers
Gerwin Heller et al.
CLINICAL CANCER RESEARCH (2012)
5-Aza-2′-deoxycytidine reactivates gene expression via degradation of pRb pocket proteins
Zhixing Zheng et al.
FASEB JOURNAL (2012)
14-3-3σ mediates G2-M arrest produced by 5-aza-2′-deoxycytidine and possesses a tumor suppressor role in endometrial carcinoma cells
Michael Steiner et al.
GYNECOLOGIC ONCOLOGY (2012)
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Peter A. Jones
NATURE REVIEWS GENETICS (2012)
5-Aza-2′-deoxycytidine-induced genome rearrangements are mediated by DNMT1
A. Y. Maslov et al.
ONCOGENE (2012)
Demethylation of the Coding Region Triggers the Activation of the Human Testis-Specific PDHA2 Gene in Somatic Tissues
Ana Pinheiro et al.
PLOS ONE (2012)
Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation
Yu-Wen Zhang et al.
PLOS ONE (2012)
Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
Zarina J. D'Costa et al.
PLOS ONE (2012)
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
Richard L. Momparler
PHARMACEUTICALS (2012)
The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2′deoxycytidine (decitabine) are differentially regulated by cell cycle progression
Mazin Al-Salihi et al.
EPIGENETICS (2011)
Pharmacokinetic evaluation of decitabine for the treatment of leukemia
Jeffrey Bryan et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Epigenetic regulation in myelodysplastic syndromes: implications for therapy
Ernesto Vigna et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Nuclear Receptors TR2 and TR4 Recruit Multiple Epigenetic Transcriptional Corepressors That Associate Specifically with the Embryonic β-Type Globin Promoters in Differentiated Adult Erythroid Cells
Shuaiying Cui et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Charting histone modifications and the functional organization of mammalian genomes
Vicky W. Zhou et al.
NATURE REVIEWS GENETICS (2011)
Azacytidine and Decitabine Induce Gene-Specific and Non-Random DNA Demethylation in Human Cancer Cell Lines
Sabine Hagemann et al.
PLOS ONE (2011)
Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome
Taichun Qin et al.
PLOS ONE (2011)
Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer
Duncan Sproul et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells
Hume Stroud et al.
GENOME BIOLOGY (2011)
Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma
Jill C. Rubinstein et al.
BMC MEDICAL GENOMICS (2010)
CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors
Jinhua Xu et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
5-azacytidine treatment reorganizes genomic histone modification patterns
Vitalina M. Komashko et al.
Epigenetics (2010)
Conserved role of intragenic DNA methylation in regulating alternative promoters
Alika K. Maunakea et al.
NATURE (2010)
Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition
A. Lakshmikuttyamma et al.
ONCOGENE (2010)
Equitoxic Doses of 5-Azacytidine and 5-Aza-2′Deoxycytidine Induce Diverse Immediate and Overlapping Heritable Changes in the Transcriptome
Xiangning Qiu et al.
PLOS ONE (2010)
Epigenetic DNA-(cytosine-5-carbon) modifications: 5-aza-2'-deoxycytidine and DNA-demethylation
S. K. Patra et al.
BIOCHEMISTRY-MOSCOW (2009)
Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell lines
Taichun Qin et al.
BLOOD (2009)
Targeting DNA Methylation
Jean-Pierre J. Issa et al.
CLINICAL CANCER RESEARCH (2009)
Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells
S. H. Lee et al.
ONCOGENE (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
A novel effect of DNA methyltransferase and histone deacetylase inhibitors -: NFκB inhibition in malignant myeloblasts
Claire Fabre et al.
CELL CYCLE (2008)
DNA methylation inhibitor 5-aza-2 '-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B
Stela S. Palii et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Stability and flexibility of epigenetic gene regulation in mammalian development
Wolf Reik
NATURE (2007)
Functional cooperation between HP1 and DNMT1 mediates gene silencing
Andrea Smallwood et al.
GENES & DEVELOPMENT (2007)
Identification of epigenetically silenced genes in tumor endothelial cells
Debby M. E. I. Hellebrekers et al.
CANCER RESEARCH (2007)
5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3K9 di-methylation levels are linked to tumor suppressor gene reactivation
R. J. Wozniak et al.
ONCOGENE (2007)
Identification of methylation-associated gene expression in neuroendocrine pancreatic tumor cells
Nils Habbe et al.
PANCREATOLOGY (2007)
Epigenetic regulation of tumor endothelial cell anergy:: Silencing of intercellular adhesion molecule-1 by histone modifications
Debby M. E. I. Hellebrekers et al.
CANCER RESEARCH (2006)
DNA hypermethylation of myeloid cells, a novel therapeutic target in MDS and AML
Claudia I. Mueller et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2006)
The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells
Hongwei Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
Yoshimasa Saito et al.
CANCER CELL (2006)
Identification of novel target genes by an epigenetic reactivation screen of renal cancer
Inmaculada Ibanez de Caceres et al.
CANCER RESEARCH (2006)
Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation
Kevin Pruitt et al.
PLOS GENETICS (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Genomic DNA methylation: the mark and its mediators
RJ Klose et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Stat1 expression is not sufficient to regulate the interferon signaling pathway in cellular immortalization
L Tang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)
5-Aza-2 '-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation
SA Scott et al.
LEUKEMIA RESEARCH (2006)
Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1
I Hernández-Muñoz et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The diverse functions of histone lysine methylation
C Martin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
DNA methylation and histone modifications: teaming up to silence genes
F Fuks
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Epigenetic treatment of hematopoietic malignancies:: In vivo targets of demethylating agents
R Claus et al.
SEMINARS IN ONCOLOGY (2005)
Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene
S Kusy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2005)
Pharmacology of 5-Aza-2′-deoxycytidine (decitabine)
RL Momparler
SEMINARS IN HEMATOLOGY (2005)
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2′-deoxycytidine treatment is associated with activation of the interferon signalling pathway
E Missiaglia et al.
ONCOGENE (2005)
Induction of gene expression by 5-Aza-2 '-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms
K Schmelz et al.
LEUKEMIA (2005)
5-aza-2′-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation
WG Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2 '-deoxycytidine
AR Karpf et al.
MOLECULAR PHARMACOLOGY (2004)
Epigenetic silencing of multiple interferon pathway genes after cellular immortalization
OI Kulaeva et al.
ONCOGENE (2003)
Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer
Y Kondo et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway
D Lavelle et al.
LEUKEMIA RESEARCH (2003)
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer
H Suzuki et al.
NATURE GENETICS (2002)
Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells
WG Zhu et al.
ONCOGENE (2001)
5-aza-2′-deoxycytidine induces histone hyperacetylation of mouse centromeric heterochromatin by a mechanism independent of DNA demethylation
S Takebayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells
J Worm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
MS Soengas et al.
NATURE (2001)
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
MR Rountree et al.
NATURE GENETICS (2000)
DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters
KD Robertson et al.
NATURE GENETICS (2000)
DNA methyltransferase Dnmt1 associates with histone deacetylase activity
F Fuks et al.
NATURE GENETICS (2000)
Share Paper
